EuroBiotech: More Articles of Note


> Lundbeck terminated development of Lu AF35700 in the wake of the failure of the drug in patients with schizophrenia. Release 

> Analysts at Jefferies raised their price target for Genmab after reviewing the prospects of its pipeline programs. Genmab reported first-half results this week. Statement 

> The Dementia Discovery Fund invested £6.5 million ($7.9 million) in AstronauTx, a startup that aims to treat Alzheimer’s disease by targeting astrocytes. Release 

> AC Immune entered into a neurodegenerative disease research collaboration with the University of Pennsylvania. Statement 

> Scotland’s Synpromics accepted a takeover offer from AskBio. Release